N-isobutyrylcysteine, a donor of systemic thiols, does not reduce the exacerbation rate in chronic bronchitis.

N-isobutyrylcysteine (NIC), a new thiol compound that is not rapidly hydrolysed to give higher levels of free thiols in the body than N-acetylcysteine (NAC), was used to test if the effect of NAC on exacerbations in chronic bronchitis was an effect of the unhydrolysed thiol compound. Smokers or exsmokers with chronic bronchitis forced expiratory volume in one second (FEV1) >40% and reversibility < or = 10% predicted were treated with oral NIC 300 mg b.i.d. or placebo for 24 weeks. Steroids, NAC, antibiotics, and nonsteroid anti-inflammatory drugs use were restricted. Exacerbations were recorded by a respiratory symptom diary card and the time to onset of the first exacerbation after the start of treatment was measured using life-table analysis. Spirometry was performed at each visit. Six hundred and thirty-seven patients were randomized to treatment with NIC (n=316) or placebo (n=321). NIC did not prolong the time to first exacerbation (life-table analysis, p=0.59) and no increase in FEV1 or forced vital capacity was observed. Altered taste perception, taste loss and anosmia occurred more often in the NIC group (p<0.001). In conclusion, N-isobutyrylcysteine, a N-acetylcysteine-like drug with a greater bioavailability has, contrary to N-acetylcysteine, no effect on exacerbations in chronic bronchitis. This suggests that the effect of N-acetylcysteine on exacerbations in chronic bronchitis is not due to the relatively low free thiol levels (other than glutathione) produced by N-acetylcysteine therapy.

[1]  W. MacNee,et al.  Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. , 1994, Thorax.

[2]  S. Anderson,et al.  Airway responsiveness : standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults , 1993 .

[3]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[4]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[5]  W. MacNee,et al.  Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine. , 1991, Thorax.

[6]  A. Tunek,et al.  Metabolism of N-acetyl-L-cysteine. Some structural requirements for the deacetylation and consequences for the oral bioavailability. , 1989, Biochemical pharmacology.

[7]  D. Coulter,et al.  Captopril: 4 years of post marketing surveillance of all patients in New Zealand. , 1987, British journal of clinical pharmacology.

[8]  G. Parr,et al.  Oral Fabrol (oral N-acetyl-cysteine) in chronic bronchitis. , 1987, British journal of diseases of the chest.

[9]  I. Jaffe.  Adverse effects profile of sulfhydryl compounds in man. , 1986, The American journal of medicine.

[10]  Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee. , 1985, Thorax.

[11]  G. Boman,et al.  Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. , 1983, European journal of respiratory diseases.

[12]  J. Mitchell,et al.  Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. , 1983, The Journal of clinical investigation.

[13]  J. Critchley,et al.  Intravenous N-acetylcysteine: still the treatment of choice for paracetamol poisoning. , 1979, British medical journal.

[14]  Long-term oral acetylcysteine in chronic bronchitis. a double-blind controlled study. , 1980, European journal of respiratory diseases. Supplement.

[15]  J. Critchley,et al.  Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. , 1979, British medical journal.

[16]  J. Wyatt,et al.  Chronic Bronchitis, Asthma, and Pulmonary Emphysema , 1962 .